Biochemistry Funding: Addition to Primary List

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institutes of Health (NIH)

5-Jan-25

$3,000,000USD

Ocular Laboratory for Analysis of Biomarkers (OCULAB)

Advanced Research Projects Agency for Health (ARPA-H)

National Institutes of Health (NIH)

27-Jan-25

Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)

National Institutes of Health (NIH)

5-Feb-25

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

National Cancer Institute (NCI)

National Institutes of Health (NIH)

13-Feb-25

$275,000USD

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health (NIH)

21-Feb-25

Basic Science Research Grant

International Society for the Study of the Lumbar Spine

28-Feb-25

$20,000USD

Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)

National Institutes of Health (NIH)

3-Mar-25

$275,000USD